Publication | Closed Access

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

ObesityNon-pharmacological InterventionWeight LossPharmacologyClinical TrialsWeight ManagementObesity ManagementPharmacotherapyPhase 2MedicineHealth Sciences